Skip to main content
. 2013 Jan;5(1):a011106. doi: 10.1101/cshperspect.a011106

Figure 1.

Figure 1.

Models for activation of MOMP effectors. (A) Derepressor model. (B) Direct activator model. (C) Current model, which is a refinement of the two former models. Antiapoptotic Bcl-2-like Bcl-XL proteins inhibit both direct activator BH3-proteins (MODE1) and effectors Bax and Bak (MODE2). Inhibition through Bcl-XL is relieved by sensitizer BH3-only proteins.